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Abstract  
 
Over recent years, quantification of multiple proteins in body fluids has become increasingly 
prominent, which is beneficial to a number of scientific fields, not least biomedical. Several 
techniques have been developed based on conventional ELISA; one of these techniques is 
analysis of proteins labelled with element-tagged antibodies by ICP-MS in serum, allowing 
quantification of multiple targets within a single sample. This research aimed to quantify 
albumin and immunoglobulin G (IgG) levels in plasma, whole blood and dried blood spots using 
NANOGOLD® and Europium labelled antibodies analysed by ICP-MS. Before the proteins were 
quantified simultaneously, albumin and IgG concentrations were measured separately and 
compared to protein levels obtained by ELISA. It was found that protein concentrations for both 
albumin and IgG obtained with element-labelled antibody detection correspond to those 
determined by ELISA. Furthermore, albumin and IgG levels measured simultaneously by ICP-MS 
correspond to concentrations found when the proteins were analysed separately by ICP-MS. 
Finally, development of this method has provided a positive indication that it can be extended to 
quantification of additional proteins, which could be related to a disease or as a minimum 
provide additional information for a protein profile of an individual.   
 
 
 
1.0 Introduction 
 
Over the last few decades biological markers have become more prominent for diagnosis of 
diseases [1,2]. A biological marker or biomarker is a characteristic found in biological fluids or 
tissues that can be measured objectively and evaluated as a sign of normal or abnormal 
biological processes [2–4]. Biomarkers can be divided in two types: biomarkers of exposure and 
biomarkers of disease [1]. Biomarkers of exposure are used to predict the risk of developing a 
disease, especially when the disease is toxin or chemical based. The second type, biomarkers of 
disease, are often used in screening, diagnosis and monitoring of disease progression. Although 
protein quantification is more common in clinical diagnosis, it is used in other disciplines as 
well - for example forensic science. Proteins can provide information about anthropometrical 
measures of an individual or identify life style factors that influence ageing of an individual [5]. 
Furthermore, a post-mortem interval estimation can be given by proteins that are involved in 
cellular changes in blood after death [6]. Although a biomarker can be used to detect difference 
in biological fluids and therefore the human body, analyses of a single protein is often not 
sufficient due to limited specificity and sensitivity of biomarkers for clinical diagnosis [7]. 
 
One of the most common techniques used for protein quantification in biological fluids is 
Enzyme-Linked ImmunoSorbent Assay (ELISA) [8]. An ELISA quantifies proteins using 
antibodies and enzyme-substrate complexes that induce colour formation, which can be 
detected by a microplate reader [9]. Unfortunately, ELISA is restricted to quantification of a 
single protein per analysis and to quantify multiple biomarkers in one sample multiple ELISAs 
must be running simultaneously leading to an increase in cost and time. To enable simultaneous 
analyses of multiple proteins several multiplex ELISA techniques have been developed, such as 
dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA™; PerkinElmer, Boston, 
USA), Quantibody: Multiplex ELISA Array (RayBiotech, Norcross, GA), Luminex™ (Luminex 
Corporation, Austin TX, USA) and Bio-plex® Multiplex Immunoassays (BioRAD, Hemel 
Hempstead, UK). Both Luminex™ and Bio-plex® systems employ colour coded beads where 
primary antibodies for one specific protein are attached to one colour. The secondary 
antibodies are labelled with a fluorescent dye and the beads are detected with flow cytometry. 
The Quantibody and DELFIA™ systems make use of both antibody detection and fluorescence, 
where Quantibody uses a streptavidin-conjugated fluorescent label, and DELFIA™ labels 
antibodies with fluorescent lanthanides. Other research has focused on using Inductively 
Coupled Plasma Mass Spectrometry (ICP-MS) alone or in combination with Laser Ablation (LA) 
or Flow Cytometry (Mass Cytometry) for detection of multiple proteins with element-tagged 
antibodies, which opens a variety of possibilities for protein quantification in biological fluids 
[3,7,10–14]. ICP-MS analyses elements by nebulizing the sample into plasma, which ionizes the 
elements in the sample, after which they are separated by mass spectrometry based on their 
mass to charge ratio [15]. Differences between ICP-MS, LA-ICP-MS and Mass Cytometry can be 
found in sample introduction, such as a nebulizer for ICP-MS and a laser for LA-ICP-MS, and 
sample preparation, such as the production of single-cell suspensions for Mass Cytometry and 
liquid samples for ICP-MS samples [10,15]. Mass Cytometry is a variation of Flow Cytometry 
combined with ICP-MS and separates single cells by labelling multiple internal and external 
markers with element-tagged antibodies instead of labelling these markers with fluorophore 
dyes, which are used in Flow Cytometry [10]. With Mass Cytometry it is possible to 
simultaneously analyse up to 31 different markers, which shows the applicability of ICP-MS for 
element-tagged antibody detection [11,16]. In comparison to other immunoassay techniques, 
ICP-MS has additional advantages, such as detection limits of around 1 part per trillion (ppt) for 
almost every element and a linear dynamic range greater than 7 orders of magnitude [3,11]. 
Furthermore it is possible to simultaneously analyse eight proteins with LA-ICP-MS by labelling 
the proteins with antibodies tagged with eight different lanthanides [11]. 
 
Sample sources used in publications about analysis of multiple proteins are human serum and 
cell lysates of several cell lines. However, for biological analysis in clinical diagnosis or 
therapeutic drug monitoring human serum and plasma obtained by venepuncture are often 
used [17,18]. Over recent years more interest has developed in the collection of blood by the 
finger prick method, after which blood drops are collected on a filter paper and dried, to 
produce so-called ‘dried blood spots’ (DBS). This method is based on the heel prick method 
used for newborn screening in which the DBS are analysed for more than 50 treatable inborn 
disorders [19,20]. The collection of blood with a finger prick instead of a venepuncture is less 
invasive and the collection of DBS provides other advantages, such as lower costs for storage, 
analyte stability and deactivation of pathogenic agents by the filter paper [17]. Another field 
that benefits from the growing development in the analysis of DBS is forensic sciences; for 
example the detection of drugs of abuse [21]. Furthermore, it is possible to collect basic 
anthropometrical measures for an individual from DBS [5].  
 
Although multiple protein quantification methods are developed for Mass Cytometry and LA-
ICP-MS, there is still much to gain in method development for multiple protein quantification 
with ICP-MS. Several publications can be found on element-tagged antibody detection analysed 
with ICP-MS, which confirm the possibility of quantifying proteins with this mass spectrometry 
technique [3,13,14,22]. Here we present in a single manuscript a novel proof of concept study to 
develop a method for simultaneous quantification of proteins in human plasma, whole blood 
and dried blood spots (DBS) using element-tagged antibodies analysed with ICP-MS. In this 
research the possibility of analysing the two most abundant blood proteins, as a simple model, 
albumin and immunoglobulin G (IgG), with element-tagged antibodies analysed by ICP-MS was 
shown. In addition, it was found that both proteins cannot only be analysed in human plasma, 
but also in whole blood samples and dried blood spots with ELISA and ICP-MS. Furthermore, it 
was shown that albumin and IgG can be analysed simultaneously with element-tagged 
antibodies analysed by ICP-MS. This work also further highlights how the DBS specimen could 
be exploited more widely than is currently used in a clinical setting. 
 
 
 
2.0 Materials and methods 
 
2.1 Blood sampling and preparation 
Finger prick blood samples of small volumes (up to 40 µl) were collected from a healthy female 
volunteer. Prior to sampling the working area and hands of the volunteer were sanitized using 
antiseptic swabs. Fingers were pricked with Unistik 3 Neonatal & Laboratory lancets (Gauge: 
1.2mm; Depth: 1.8 mm; Owen Mumford, Woodstock, UK) and 40 μl whole blood was collected 
with lithium heparin-coated capilliary tubes (Cholestech LDX, Alere, San Diego, USA). Samples 
consisting of 40 μl whole blood were either used in fluid state immediately or spotted onto Spot 
Saver cards (PerkinElmer, Greenville, USA) before being left to dry for 24 hours at room 
temperature. Bloods spots were cut from Spot Saver cards and blood was extracted from the 
discs by immersing in tubes containing 4 ml of ultra-pure deionised water. The tubes were 
placed in a 40°C water bath for 60 minutes. After 60 minutes the tubes were removed from the 
water bath and cooled at room temperature before removing the disks. The samples were used 
immediately or stored at 4°C prior to analysis. Human plasma was separated from 80 µl of 
whole blood by centrifuging at 14000 rpm for 10 minutes and used immediately or stored at -
20°C. For analysis whole blood samples and dried blood spots were diluted 1:5000 and plasma 
samples were diluted 1:10000.  
 
Samples for a set of experiments were taken at the same timepoint. Biological replicates were 
three for plasma samples and two each for DBS and whole blood. For technical replicates 
(where standard deviation is shown in Results) - IgG is 4 or 5 samples and albumin is 3 or 4 
samples. 
 
2.2 ELISA 
(A review of ELISA methodology can be found in [9].) Human albumin was analysed with a 
competitive Albumin Human ELISA kit (Abcam, Cambridge, UK) according to manufacturer’s 
protocol. 0.05% Tween 20 (Sigma-Aldrich, Gillingham, UK) in Dulbecco's Phosphate Buffered 
Saline (D-PBS; Gibco®, ThermoFisher Scientific, Paisley, UK) was used as a wash buffer. The 
microplates were analysed with a Wallac Victor2 1420 multilabel counter microplate reader 
(PerkinElmer) at a wavelength of 450 nm.  
 
For analysis of human IgG, a Nunclon™ Delta Surface 96 wells plate (ThermoFisher Scientific) 
was coated with 0.8 µg/ml Goat-anti-human IgG (Sigma-Aldrich) in D-PBS for 2 hours at room 
temperature or overnight at 4°C. Samples and standards were diluted in D-PBS with 0.05% 
Tween 20 and 1% bovine serum albumin (BSA; Sigma-Aldrich) and incubated for 90 minutes at 
room temperature. Pentaglobin® (Biotest, Dreieich, Germany) was used as an IgG standard. 
After washing with 0.05% Tween 20 in D-PBS, 100 ng/ml Mouse-anti-human IgG Europium 
(Eu)-labelled antibody (DELFIA®; PerkinElmer) was diluted in D-PBS with 0.05% Tween 20 
and 1% BSA and incubated for 1 hour. After washing 100 µl of DELFIA® Enhancement solution 
(PerkinElmer) was added per well and incubated for 15 minutes at room temperature on a 
shaker to release Europium, which can then form a bright enhancing chelate enabling analysis 
with the Europium programme of the  Wallac Victor2 1420 multilabel counter microplate reader. 
 
For the ELISAs the samples were measured in duplicate and the ELISA performed at least 3 
times. On the final occasion n=5.  
  
2.3 Instrumental parameters 
Elemental compositions were determined using a NexIon 350X ICP-MS instrument 
(PerkinElmer). Typical operating parameters are listed in Table 1. Samples were introduced 
into the instrument with a S10 Autosampler for ICP-MS (PerkinElmer).  
 
To eliminate carryover of gold, wash solutions containing 5% aqua regia and 10 mM L-cysteine 
(Sigma-Aldrich) were used. Before gold analysis the instrument was rinsed for 60 minutes with 
both wash solutions (this method development is included in the Supplementary Materials). 
 
 
 
Operating parameters  
Plasma power 1600 W 
Plasma gas (Ar) flow rate 18 L/m 
Auxiliary gas (Ar) flow rate 1.2 L/m 
Nebuliser gas (Ar) flow rate 0.89 L/m 
Sample flush time 55 s 
Sample flush speed 24 rpm 
Read delay 35 s 
Delay/Analysis speed 20 rpm 
Sweeps/Reading 200 
Readings/Replicate 1 
Replicates 3 
Wash delay 60 s 
Wash speed 24 rpm 
Applied liquid flow rate 1 mL/m 
Dwell time per isotope 50 ms 
Isotopes monitored 197Au, 193Ir; 
151/153Eu, 115In 
 
 
 
2.4 Element based single protein detection assays  
Human albumin was analysed with NANOGOLD® (Universal Biologicals, Cambridge, UK) 
labelling using a competitive Albumin Human ELISA kit. The assay protocol was based on the 
protocol of the Albumin Human ELISA kit and the method developed by Thompson et al. [3] for 
analysis of VEGF with NANOGOLD® labelling. After the samples and the biotinylated albumin 
were incubated for one hour at room temperature the wells were washed with 0.05% Tween 20 
in D-PBS. Subsequently 50 µl of NANOGOLD®-streptavidin (1:500 diluted in 0.1% FCS in PBS) 
was added to the wells and incubated for another hour at room temperature. The wells were 
washed again, 200 µl of 2% HNO3 (Sigma-aldrich) was added and the plate was shaken for 30 
minutes at ~180 rpm. The samples were diluted further in 3 or 6 ml of 2% HNO3 spiked with 
Iridium (PerkinElmer) as an internal standard for analysis with the ICP-MS instrument.  
 
Human IgG was analysed with a Mouse-anti-IgG Eu-labelled antibody using the IgG ELISA 
protocol. After incubation of the Eu-labelled antibody the wells were washed and 200 µl of 2% 
HNO3 was added after which the plate was shaken for 30 minutes at ~180 rpm. The samples 
Table 1. Typical operating parameters of the NexIon 
350X ICP-MS. 
were diluted further in 3 or 6 ml of 2% HNO3 spiked with Indium (BDH spectrosol; VWR 
international, Radnor, USA) as an internal standard for analysis with the ICP-MS instrument. 
 
ICPMS was repeated at least 3 times and on the final occasion n=5. Calibration curves were 
measured in duplicate pre- and post-run and the samples themselves just once (but the 
instrument taking 3 measurements and giving an average). 
 
2.5 Element based multiple protein detection assay 
For simultaneous quantification of IgG and Albumin a Nunclon™ Delta Surface 96 wells plate 
was coated with 0.8 µg/ml Goat-anti-human IgG and 1:60.000 Rabbit-anti-human Albumin 
(Sigma-Aldrich) and incubated for 2 hours at room temperature or overnight at 4°C. Standards 
and samples were diluted in PBS with 1% BSA and 0.05% Tween 20 and incubated for 90 
minutes. 75 µl sample or standard was added to each well with 25 µl of 2x Biotinylated Albumin 
(Albumin Human ELISA Kit; Abcam). Standards employed were Pentaglobin® (Biotest) and 
Albumin standard of the Albumin Human ELISA Kit (Abcam). After washing with 0.05% Tween 
20 in PBS 100 ng/ml Mouse-anti-human IgG Eu-labelled antibody (DELFIA®; PerkinElmer) and 
1:500 NANOGOLD®-streptavidin was incubated for 1 hour. After incubation of the Eu-labelled 
antibody and NANOGOLD®-streptavidin the wells were washed and 200 µl of 2% HNO3 was 
added after which the plate was shaken for 30 minutes at ~180 rpm. The samples were diluted 
further in 3 or 6 ml of 2% HNO3 spiked with indium and iridium as internal standards for 
analysis with the ICP-MS instrument. Experiments were repeated twice for DBS and fresh blood, 
and three times for plasma. Figure 1 shows a schematic representation of the method.   
 
 
 
 
 
 
  
 
Figure 1. Schematic representation of the element based detection of albumin and IgG. 
3.0 Results 
 
3.1 Quantification of albumin levels with ELISA and ICP-MS 
 
Albumin is one of the most abundant proteins present in whole blood and was therefore chosen 
to be quantified by ICP-MS following labelling with NANOGold®-tagged antibodies. Iridium was 
used as an internal standard to normalize the data obtained by ICP-MS analysis. Figure 2C 
shows that gold counts normalized using the internal standard iridium provided a superior 
calibration curve compared to a gold calibration curve without the use of an internal standard 
(Figure 2A). For both calibration curves containing gold, the gold values of standard 1 were 
higher in comparison to standard 2. To confirm that there was no carry-over from iridium a 
calibration was done leading to a R2 of 0.9999, which can be seen in Figure 2B.  
 
To prove the feasibility of protein quantification with ICP-MS measured albumin levels were 
compared to albumin levels measured with an ELISA. It was found that there was no difference 
between albumin levels measured with ELISA or ICP-MS (Figure 3A). Furthermore, it was found 
that there was no significant difference between whole blood and plasma albumin levels in both 
ELISA and ICP-MS measurements. However, albumin levels in dried blood spots were 
significantly lower in comparison to whole blood and plasma albumin levels measured with 
both ELISA and ICP-MS. Although albumin levels measured with ICP-MS had a larger standard 
deviation in comparison to albumin levels quantified with ELISA, there was a strong correlation 
between albumin levels measured by both techniques (Figure 3B). The correlation analysis 
showed a R2 of 0.9025 and a p value of 0.0004, which indicates that the correlation is not due to 
random sampling. Figure 3C and D show albumin calibration curves measured with ELISA and 
ICP-MS from which albumin concentrations were determined. (A negative curve is observed as 
expected for competitive ELISA in both cases.) For ICP-MS lower albumin concentrations (0, 1.5, 
3, 6 and 12 μg/ml) were observed, indicating a higher sensitivity of protein quantification with 
ICP-MS.  
 
These results show that it is possible to quantify albumin levels with element-tagged antibodies 
quantified by ICP-MS. In addition, it was shown that the competitive Albumin Human ELISA kit 
cannot only be used to quantify albumin levels in plasma, but can quantify albumin levels in 
whole blood and dried blood spots as well.  
 
 
 
 
Figure 2. A) Calibration curve of gold. B) Calibration curve of iridium. C) Calibration curve of gold with 
iridium as internal standard. 
 
 
3.2 Quantification of IgG levels with ELISA and ICP-MS 
Immunoglobulin G was chosen to be quantified as the second protein in this study. IgG was 
labelled with a europium-tagged antibody for analysis with ICP-MS. In this instance, indium was 
used as an internal standard. In Figure 4 calibration curves of both europium isotopes (151 and 
153) and indium are shown. All three calibration curves gave a perfect fit with R squared values 
between 0.9998 and 1.000, suggesting there is no carry-over effect between standards.  
 
IgG levels were measured in whole blood, plasma and DBS with ICP-MS and ELISA and no 
significant difference in IgG concentrations obtained by both techniques was found (Figure 5A). 
In addition, there was no significant difference in IgG concentrations found between plasma and 
whole blood samples. However, IgG levels in DBS were significantly higher in comparison to IgG 
levels found in plasma and whole blood samples. A correlation analysis of IgG levels measured 
with ELISA and ICP-MS confirm that there was no difference between IgG concentrations in 
plasma, whole blood and DBS measured with both techniques (Figure 5B). Figure 5C and D 
show the calibration curves measured with ICP-MS and ELISA that were used for determination 
of IgG levels in the samples.  
 
Figure  3. A) Albumin concentrations in whole blood, plasma and dried blood spots analysed by ICP-MS 
and ELISA. B) Correlation analysis of albumin levels measured with ELISA and ICP-MS with a p value of 
0.0004. C) Albumin calibration curve measured with ICP-MS. D) Albumin calibration curve measured with 
ELISA. [DBS: Dried blood spots]. NB. Where error bars are smaller than the spots, they are not shown.  
These results show that it is possible to quantify albumin levels with element-tagged antibody 
detection using ICP-MS. 
 
 
 
 
 
3.3 Albumin and IgG simultaneous quantification 
After it was shown that blood proteins albumin and IgG can be analysed using NANOGold® and 
europium-labelled antibody detection coupled with ICP-MS, concentrations of both proteins 
were measured simultaneously. Albumin and IgG levels were measured separately and 
Figure 4. A) Calibration curve of europium 151. B) Calibration curve of europium 153. C) Calibration 
curve of indium 115.  
Figure 5. A) IgG levels in plasma, whole blood and dried blood spots analysed by ICP-MS and ELISA. B) 
Correlation analysis of IgG levels measured with ELISA and ICP-MS with a p value of 0.0001. C) IgG 
calibration curve measured with ICP-MS. D) IgG calibration curve measured with ELISA. [DBS: Dried 
blood spots].  
simultaneously in plasma, whole blood and DBS to prove the feasibility of simultaneous protein 
quantification. Albumin levels measured in all three sample sources showed no significant 
difference between separate analysis of albumin and analysis of albumin in combination with 
IgG (Figure 6A). In addition, there was no significant difference in albumin levels between 
plasma, whole blood and DBS. In Figure 6B it is shown that there was no significant difference in 
IgG concentrations determined with separate analysis and analysis of IgG combined with 
albumin. However, there was a significant difference between IgG levels measured in plasma, 
whole blood and DBS.  
 
 
 
 
 
Figure 6. A) Albumin concentrations analysed in whole blood, plasma and DBS in a separate assay and 
an assay combined with IgG. B) IgG concentrations analysed in plasma, whole blood and DBS in a 
separate assay and an assay combined with albumin. n = 5 for all [DBS: dried blood spots].  
4.0 Discussion 
 
 
Albumin was chosen to be the first protein to be analysed with element-labelled antibody 
detection, since it is the most abundant protein in blood [23]. Furthermore, normal albumin 
concentrations in blood are between 30 – 50 mg/ml and changes in albumin levels can indicate 
kidney or liver failure. In this study it was shown that albumin levels of the blood donor fall in 
this concentration range. In addition, it was shown that albumin concentrations obtained with a 
NANOGOLD® label correspond to levels obtained by a competitive ELISA for human albumin, 
indicating feasibility of this method. Although NANOGOLD® has advantages over other metal-
based labels, such as lower detection limits, carry over effect of gold particles might be an issue 
for the use of this label for clinical diagnosis or forensic protein profiling [3]. Without the use of 
an efficient wash method, such as the one developed for this method, the gold counts observed 
cannot be deemed reliable and therefore it is not possible to accurately determine protein levels 
for an individual. With addition of an efficient wash method the protein concentrations obtained 
from the calibration curves are reliable, since the concentrations match protein levels found by 
ELISA. However, to improve the feasibility of this method and to reduce the time needed for the 
analysis it might be more efficient to use a lanthanide label, such as the Europium label used for 
quantification of IgG in this study.  
 
For quantification of the second protein, antibody IgG, an ELISA was developed based on a 
DELFIA system. It was shown that protein levels obtained with europium-labelled antibody 
detection analysed by ICP-MS correspond to concentrations observed for IgG by ELISA. 
Europium is common in element-labelled antibody detection, since it is a rare earth element and 
it has fluorescent properties [11,13]. Should this method be developed further, the use of more 
lanthanides would be considered due to their high sensitivity in biological samples and the ease 
of lanthanides to bind to biomolecules [13].  
 
In dried blood spots IgG levels were increased in comparison to IgG concentrations in plasma 
and whole blood, which might be caused by the extraction method of DBS. The extraction 
method used for this study is a common method and based on previous findings of the research 
group [24]. To extract DBS from the filter paper, spots were placed in 4 mL of ultra-pure 
deionized water and heated for an hour at 40°C. Normal body temperature is on average 37°C 
and a 3°C increase in temperature might induce degradation of proteins, which creates more 
IgG binding sites and therefore increasing IgG levels. Another possibility for a change in protein 
levels in DBS are storage conditions. Adam et al. [19] showed that low and high humidity can 
cause large changes in the degree and rapidity of degradation. In this study storage conditions 
could not be strictly regulated and fluctuations in humidity were possible.  
 
 
 
 
 
 
 
 
5.0 Conclusion 
 
Quantification of proteins plays an important role in a number of scientific fields and it is often 
necessary to analyse multiple proteins in one sample. In this research a method was developed 
to analyse two proteins, albumin and IgG, simultaneously in plasma, whole blood and dried 
blood spots with element-labelled antibody detection using ICP-MS. For both proteins it was 
shown that protein concentrations obtained by element-labelled antibody detection using ICP-
MS correspond to those determined by ELISA. Furthermore, the possibility of simultaneous 
quantification of albumin and IgG with element-labelled antibody detection using ICP-MS was 
proven. The choice to use these two abundant proteins has enabled proof of concept and a 
simple model to be established that illustrates the effectiveness of ICPMS analysis via the DBS 
sample approach and serves as a reminder that this specimen can be as useful as liquid 
specimens but with major advantages 
 
Although the methodology in this study is developed for quantification of human proteins in 
biological fluids, this method can be used for anabolic purposes as well. For example, the 
identification of anabolic-androgenic steroids (AASs) in biological fluids in doping controls [25]. 
AASs are used by athletes to improve their performance or physical appearance and the 
structures of AASs are based on ordinary human hormones, so the steroids can bind to 
receptors in the human body [26]. Since AASs are very similar to ordinary human hormones 
difficulties in detection are encountered. With use of element-labelled antibody detection and 
the production of antibodies with specific binding sites for AASs trace amounts of these steroids 
can be detected by ICP-MS.  
 
For future research this method can be extended by incorporating the quantification of 
additional proteins through tagging with multiple elements. Any further extension to the 
methodology must take into consideration cross reactivity between antibodies. Previously it 
was mentioned that multiple protein quantification can be beneficial for two fields, medical and 
forensic. Proteins that will be selected for furthering this research should either be related to a 
disease, so a new diagnostic method can be developed, or give relevant information that could 
help form a forensic profile, such as proteins that are correlated with anthropometrical 
measurements [5]. Furthermore, the feasibility of this method for use in clinical diagnosis or 
forensic cases should be proven by re-diagnosis of patient samples or linking unknown blood 
samples to a suspect based on the protein profile of the sample.   
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